129 related articles for article (PubMed ID: 38325600)
1. Pathogenic Variant Intraductal Papillary Mucinous Neoplasms Tumors Show Increased Tumor Growth Compared With Those With Familial Pancreatic Cancer Kindreds: Prognostic Indicators.
Cappell MS; Tobi M
Clin Gastroenterol Hepatol; 2024 Feb; ():. PubMed ID: 38325600
[No Abstract] [Full Text] [Related]
2. Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.
Murali K; Dwarte TM; Nikfarjam M; Tucker KM; Vaughan RB; Efthymiou M; Collins A; Spigelman AD; Salmon L; Johns AL; Williams DB; Delatycki MB; John T; Stoita A
Hered Cancer Clin Pract; 2021 Aug; 19(1):33. PubMed ID: 34399810
[TBL] [Abstract][Full Text] [Related]
3. Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk.
Overbeek KA; Koopmann BDM; Levink IJM; Tacelli M; Erler NS; Arcidiacono PG; Ausems MGE; Wagner A; van Eijck CH; Groot Koerkamp B; Busch OR; Besselink MG; van der Vlugt M; van Driel LMJW; Fockens P; Vleggaar FP; Poley JW; Capurso G; Cahen DL; Bruno MJ;
Clin Gastroenterol Hepatol; 2024 Jan; 22(1):62-71.e7. PubMed ID: 37031711
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271
[TBL] [Abstract][Full Text] [Related]
5. Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds.
Porter N; Laheru D; Lau B; He J; Zheng L; Narang A; Roberts NJ; Canto MI; Lennon AM; Goggins MG; Hruban RH; Klein AP
J Natl Cancer Inst; 2022 Dec; 114(12):1681-1688. PubMed ID: 36029239
[TBL] [Abstract][Full Text] [Related]
6. IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapy.
Kaiser J; Scheifele C; Hinz U; Leonhardt CS; Hank T; Koenig AK; Tjaden C; Hackert T; Bergmann F; Büchler MW; Strobel O
Eur J Surg Oncol; 2022 Jun; 48(6):1309-1320. PubMed ID: 34920899
[TBL] [Abstract][Full Text] [Related]
7. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.
Klein AP; Brune KA; Petersen GM; Goggins M; Tersmette AC; Offerhaus GJ; Griffin C; Cameron JL; Yeo CJ; Kern S; Hruban RH
Cancer Res; 2004 Apr; 64(7):2634-8. PubMed ID: 15059921
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous tumor: Different prognostic factors for different overall survival.
Gavazzi F; Capretti G; Giordano L; Ridolfi C; Spaggiari P; Sollai M; Carrara S; Nappo G; Bozzarelli S; Zerbi A
Dig Liver Dis; 2022 Jun; 54(6):826-833. PubMed ID: 34219044
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate Antigen 19-9 Is an Invasive Malignancy Preoperative Prognostic Factor for Intraductal Papillary Mucinous Neoplasms.
Suzuki S; Shimoda M; Shimazaki J; Oshiro Y; Nishda K; Orimoto N; Nagakawa Y; Tsuchida A
Eur Surg Res; 2021; 62(4):262-270. PubMed ID: 34344012
[TBL] [Abstract][Full Text] [Related]
10. Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene.
Hsu FC; Roberts NJ; Childs E; Porter N; Rabe KG; Borgida A; Ukaegbu C; Goggins MG; Hruban RH; Zogopoulos G; Syngal S; Gallinger S; Petersen GM; Klein AP
JAMA Oncol; 2021 Nov; 7(11):1664-1668. PubMed ID: 34529012
[TBL] [Abstract][Full Text] [Related]
11. Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN).
Fujiyama Y; Kumamoto Y; Nishizawa N; Nakamoto S; Harada H; Yokota K; Tanaka Y; Igarashi K; Oiki H; Okuwaki K; Iwai T; Kajita S; Takahashi H; Tajima H; Kaizu T; Sasaki J; Watanabe M; Yamashita K
Ann Surg Oncol; 2020 Oct; 27(10):4007-4016. PubMed ID: 32144623
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
[TBL] [Abstract][Full Text] [Related]
13. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
[TBL] [Abstract][Full Text] [Related]
14. Importance of age of onset in pancreatic cancer kindreds.
Brune KA; Lau B; Palmisano E; Canto M; Goggins MG; Hruban RH; Klein AP
J Natl Cancer Inst; 2010 Jan; 102(2):119-26. PubMed ID: 20068195
[TBL] [Abstract][Full Text] [Related]
15. Rare metastatic pancreatic tumors from lung cancer with cystic changes resembling intraductal papillary mucinous neoplasm: a case report.
Watanabe A; Harimoto N; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Kubo N; Araki K; Suzuki A; Hara K; Shirabe K
Surg Case Rep; 2020 May; 6(1):117. PubMed ID: 32468270
[TBL] [Abstract][Full Text] [Related]
16. Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinoma.
Leonhardt CS; Hinz U; Kaiser J; Hank T; Tjaden C; Bergmann F; Hackert T; Büchler MW; Strobel O
Eur J Surg Oncol; 2023 Jan; 49(1):113-121. PubMed ID: 35965217
[TBL] [Abstract][Full Text] [Related]
17. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.
Takano S; Fukasawa M; Maekawa S; Kadokura M; Miura M; Shindo H; Takahashi E; Sato T; Enomoto N
PLoS One; 2014; 9(6):e98718. PubMed ID: 24897499
[TBL] [Abstract][Full Text] [Related]
18. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
[TBL] [Abstract][Full Text] [Related]
19. F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors.
Yoshioka M; Uchinami H; Watanabe G; Sato T; Shibata S; Kume M; Ishiyama K; Takahashi S; Hashimoto M; Yamamoto Y
Springerplus; 2015; 4():154. PubMed ID: 25883884
[TBL] [Abstract][Full Text] [Related]
20. Imaging morphological changes of intraductal papillary mucinous neoplasm of the pancreas was associated with its malignant transformation but not with development of pancreatic ductal adenocarcinoma.
Kawada N; Uehara H; Nagata S; Tsuchishima M; Tsutsumi M; Tomita Y
Pancreatology; 2015; 15(6):654-60. PubMed ID: 26433405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]